Canyon Country · Newhall · Saugus · Valencia · Stevenson Ranch · Castaic · Agua Dulce
Santa Clarita Valley Business Journal Santa Clarita’s Only Business Publication
$4.50 · Volume 8 · Number 7
www.scvbj.com
Logix Federal Credit Union Breaks Ground
Page 4
november 2016
Dave Styler, President & CEO - Logix Federal Credit Union, left, and Logix Board members line up to throw dirt at the official ground breaking ceremony at the site of the the new Logix headquarters building in Valencia on Oct. 26. Photo by Dan Watson.
Six Hard-Learned Lessons Hypertension Controlling A business 36 years in the making Device eCoin Enters the Next Stage of Testing By Ken Kellar
SCVBJ Contributor
I
t is commonly known that most new businesses close the doors after a very short period of time. The statistic most quoted is that 80 percent of startups fail within two years. The number of firms that survive to the five-year mark is about 4 percent. Staying in The team at J&M Entertainment learns to navigate business beyond that, well, the a new program during their weekly staff meeting. Photo by Katharine Lotze. odds are very slim. Despite those odds, J&M Boskovich Bros. His family moved to Events celebrated being in business 36 the Santa Clarita Valley in pursuit of years earlier this year. Founded and led opportunity. by Jorge Lopez, the business has grown, Lopez has deep roots in the community stumbled, gone sideways and evolved to and he, his family and his company are meet the demands of changing market well known for contributions to various forces and demographics. The son of immigrants, Lopez and nonprofit efforts through the years. his family worked packing onions for See LESSONS page 8
By Paul Parcellin SCVBJ Editor
M
edical device maker Valencia Technologies has received the federal government’s goahead to begin human testing for its small implantable device designed to control hypertension. The device, called eCoin, is intended to help patients with drug-resistant hypertension. The coin-sized devices can be implanted in 20 minutes using a local anesthetic. They are implanted in both of a patient’s forearms, and the two neurostimulators help control the subject’s blood pressure. Jeff Greiner, CEO of Valencia Technologies, said that the ultimate goal is to eliminate the need for medications used to treat hypertension. In the first stage of testing, the toughest to treat patients in the world will be the subjects. That’s those who are on three or more medications. “We’ll demonstrate that we lower blood pressure in the hardest to treat patients,” said Greiner. “Only after that we will be allowed to take away drugs from patients and see whether we can safely replace
Jeff Greiner, CEO of Valencia Technologies. Courtesy photo.
those drugs.” The device provides “neuromodulation” therapy to control blood pressure. Greiner said it’s a therapy that changes the nervous system. “Think of the nervous system for many hypertensive patients as being in overdrive,” he said. The eCoin stimulates the nervous system, and the brain reacts by sending out chemicals that relax the nervous system and in effect lower blood pressure. See TESTING page 15